PE-22-28 vs Semax Amidate — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
PE-22-28 is a synthetic fragment of spadin (a naturally occurring peptide derived from the NTSR3/sortilin propeptide) that antagonizes TREK-1, a two-pore domain potassium channel (K2P channel) that regulates neuronal excitability. TREK-1 is strongly implicated in depression and c...
Calculate PE-22-28 dose →Semax Amidate (Semax-NH2) is Semax with C-terminal amidation - the addition of an amide group (-NH2) replacing the C-terminal carboxyl group (-COOH). This modification protects against carboxypeptidase degradation in nasal tissue, extending half-life and improving CNS bioavailabi...
Calculate Semax Amidate dose →| Parameter | PE-22-28 | Semax Amidate |
|---|---|---|
| Category | Cognitive & Neurological | Cognitive & Neurological |
| Research | Preclinical | Research Use |
| Half-Life | - | ~6 hours (estimated) |
| Typical Dose | 100–200 µg | 100–400 µg |
| Frequency | Daily | Once or twice daily |
| Route | Subcutaneous / Intranasal | Intranasal |
| FDA Status | Not Approved | Not Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.